Safety profile of herbal medicines submitted for marketing authorization in Tanzania: a cross-sectional retrospective study

References

• World Health Organization. WHO traditional medicine strategy: 2014–2023: World Health Organization; 2013.
   Google Scholar
• World Health Organization. Research guidelines for evaluating the safety and efficacy of herbal medicines: WHO Regional Office for the Western Pacific; 1993.
   Google Scholar
• Qu L, Zou W, Wang Y, Wang MEuropean regulation model for herbal medicine: the assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member StatesPhytomedicine201842219225 29655689 10.1016/j.phymed.2018.03.048
   PubMed Web of Science ®Google Scholar
• World Health Organization. Guidelines for the regulation of herbal medicines in the South-East Asia Region. WHO Regional Office for South-East Asia; 2004.
   Google Scholar
• World Health Organization. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems: World Health Organization; 2004.
   Google Scholar
• World Health Organization. Guidelines for the assessment of herbal medicines. World Health Organization; 1991.
   Google Scholar
• Calixto JBEfficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)Braz J Med Biol Res200033179189 1:STN:280:DC%2BD3c7itlyjsw%3D%3D 10657057 10.1590/S0100-879X2000000200004
   PubMed Web of Science ®Google Scholar
• Moreira DL, Teixeira SS, Monteiro MH, De-Oliveira AC, Paumgartten FJTraditional use and safety of herbal medicinesRev Bras Farmacogn2014242248257 10.1016/j.bjp.2014.03.006
   Google Scholar
• Teng L, Zu Q, Li G, Yu T, Job KM, Yang X, et al.Herbal medicines: challenges in the modern world. Part 3. China and JapanExpert Rev Clin Pharmacol20169912251233 1:CAS:528:DC%2BC28XpsVGmu7Y%3D 27232545 10.1080/17512433.2016.1195263
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Herbal medicinal products European Union: European Medicines Agency; 2022. Available from: https://www.ema.europa.eu/en/human-regulatory/herbal-medicinal-products.
   Google Scholar
• Toklu HZ. Pharmacovigilance of Herbal Medicine: Herbavigilance. Adv Pharmacoepidemiol Drug Saf. 2016;5(4).
   Google Scholar
• Kim M, Woo Y, Han C-hCurrent status of the spontaneous reporting and classification/coding system for herbal and traditional medicine in pharmacovigilanceIntegr Med Res2021101 32802741 10.1016/j.imr.2020.100467
   PubMed Web of Science ®Google Scholar
• Kamsu-Foguem B, Foguem CAdverse drug reactions in some African herbal medicine: literature review and stakeholders’ interviewIntegr Med Res201433126132 28664088 5481732 10.1016/j.imr.2014.05.001
   PubMedGoogle Scholar
• Han J, Xian Z, Zhang Y, Liu J, Liang AJFiPSystematic overview of aristolochic acids: nephrotoxicity, carcinogenicity, and underlying mechanismsFront Pharmacol201910648 1:CAS:528:DC%2BB3cXksValtbY%3D 31244661 6580798 10.3389/fphar.2019.00648
   PubMed Web of Science ®Google Scholar
• Martin KW, Ernst EHerbal medicines for treatment of bacterial infections: a review of controlled clinical trialsJ Complement Ther Med2003512241246 1:CAS:528:DC%2BD3sXovFentg%3D%3D
   Google Scholar
• Martin KW, Ernst EHerbal medicines for treatment of fungal infections: a systematic review of controlled clinical trialsMycoses2004473–48792 15078424 10.1046/j.1439-0507.2003.00951.x
   PubMed Web of Science ®Google Scholar
• World Health Organization. General guidelines for methodologies on research and evaluation of traditional medicine. World Health Organization; 2000.
   Google Scholar
• Govindaraghavan S, Sucher NJQuality assessment of medicinal herbs and their extracts: criteria and prerequisites for consistent safety and efficacy of herbal medicinesEpilepsy Behav201552363371 25899015 10.1016/j.yebeh.2015.03.004
   PubMed Web of Science ®Google Scholar
• Che C-T, Wang ZJ, Chow MSS, Lam CWKHerb-herb combination for therapeutic enhancement and advancement: theory, practice and future perspectivesMolecules201318551255141 1:CAS:528:DC%2BC3sXosFCqsLY%3D 23644978 6269890 10.3390/molecules18055125
   PubMed Web of Science ®Google Scholar
• Gromek K, Drumond N, Simas PPharmacovigilance of herbal medicinesInt J Risk Saf Med20152725565 26410008 10.3233/JRS-150643
   PubMedGoogle Scholar
• Thakkar S, Anklam E, Xu A, Ulberth F, Li J, Li B, et al.Regulatory landscape of dietary supplements and herbal medicines from a global perspectiveRegul Toxicol Pharmacol2020114 32305367 10.1016/j.yrtph.2020.104647
   PubMed Web of Science ®Google Scholar
• Dou J, Beitz J, Temple R. Development of plant-derived mixtures as botanical drugs: clinical considerations. In: Ram Sasisekharan SLL, Amy Rosenberg, Larry A. Walker, editor. The science and regulations of naturally derived complex drugs. AAPS Series 32. Cham, Switzerland: Springer 2019. p. 245–64.
   Google Scholar
• Fisher AC, Lee SL. Evolving challenges in developing naturally-derived complex mixtures into drugs: US experience and perspective. In: Ram Sasisekharan SLL, Amy Rosenberg, Larry A. Walker, editor. The science and regulations of naturally derived complex drugs. AAPS Series 32. Cham, Switzerland: Springer; 2019. p. 1–15.
   Google Scholar
• Wu LC, Raw A, Knöss W, Smith M, Zhang W-D, Bedi YS, et al. Regulatory landscapes for approval of naturally-derived complex mixture drugs. In: Ram Sasisekharan SLL, Amy Rosenberg, Larry A. Walker, editor. The science and regulations of naturally derived complex drugs. AAPS Series 32. Cham, Switzerland: Springer; 2019. p. 17–44.
   Google Scholar
• Sahoo N, Manchikanti PHerbal drug regulation and commercialization: an Indian industry perspectiveJ Altern Complement Med20131912957963 23829812 3868382 10.1089/acm.2012.0275
   PubMed Web of Science ®Google Scholar
• World Health Organization. National policy on traditional medicine and regulation of herbal medicines: Report of a WHO global survey: World Health Organization; 2005.
   Google Scholar
• Liu Y, Yang Z, Cheng J, Fan DBarriers and countermeasures in developing traditional Chinese medicine in EuropeFront Med2016103360376 27465827 10.1007/s11684-016-0455-x
   PubMed Web of Science ®Google Scholar
• Complementary medicines—use of the ZA-CTD format in the preparation of a registration application [Internet]. SAHPRA. 2020. Available from: https://www.sahpra.org.za/wp-content/uploads/2020/07/7.03_CMs_ZACTD_Jun20_v3_2.pdf.
   Google Scholar
• CTD modules 2, 3, 4 and 5 for registered complementary medicine applications Australian Regulatory guidelines [Internet]. Therapeutic Goods Administration. 2020 [cited October 2023]. Available from: https://www.tga.gov.au/sites/default/files/ctd_modules_2_3_4_and_5_for_registered_complementary_medicine_applications_0.pdf.
   Google Scholar
• Peschel WThe Traditional Herbal Medicine Directive within the European regulatory framework for herbal productsBol Latinoam Caribe Plantas Med Aromat200764102111
   Google Scholar
• Natural Health products ingredients database: Pre-Cleared Information [Internet]. Government of Canada. 2023. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/search-rechercheReq.do.
   Google Scholar
• United Republic of Tanzania. Tanzania Medicines and Medical Device Act Chapter 219. Revised 2021 ed. Dar-Es Salaam, Tanzania: Government Printer 2021.
   Google Scholar
• Tanzania Medicines and medical devices Authority. The Tanzania Food, Drugs and Cosmetics (Registration of Medicinal Products) Regulations, 2015 Dar Es Salaam Tanzania: Tanzania Medicines and medical devices Authority; 2015.
   Google Scholar
• Tanzania Medicines and Medical Devices Authority. Guidelines on submission of documentation for marketing authorization of herbal medicinal products. Dar Es Salaam: TMDA; 2020.
   Google Scholar
• Carvalho AC, Balbino EE, Maciel A, Perfeito JPSituation of herbal medicines register in BrazilRev Bras Farmacogn200818314319 10.1590/S0102-695X2008000200028
   Google Scholar
• Scholten WK, Halkes SBAIntroducing a system for the assessment of quality, safety, and efficacy of herbal medicinal products in the NetherlandsDrug Inf J2001352461468 10.1177/009286150103500214
   Google Scholar
• Peschel WThe use of community herbal monographs to facilitate registrations and authorisations of herbal medicinal products in the European Union 2004–2012J Ethnopharmacol2014158471486 25043780 10.1016/j.jep.2014.07.015
   PubMed Web of Science ®Google Scholar
• Tanzania Food and Drugs Authority. Guidelines for application for registration of Herbal Medicines in Tanzania. Dar Es Salaam: TFDA; 2004.
   Google Scholar
• Microsoft Corporation. Microsoft Excel [Internet] 2018 [Available from: https://office.microsoft.com/excel.
   Google Scholar
• IBM Corp. IBM SPSS Statistics for Windows, Version 28.0 [Internet]: Armonk NY; 2021 [cited 2021. Available from: https://www.ibm.com/se-en/products/spss-statistics?lnk=sehpv18ct7.
   Google Scholar
• Huntley AL, Coon JT, Ernst EThe safety of herbal medicinal products derived from Echinacea speciesDrug Saf2005285387400 15853441 10.2165/00002018-200528050-00003
   PubMed Web of Science ®Google Scholar
• Ernst ESerious psychiatric and neurological adverse effects of herbal medicines-a systematic reviewActa Psychiatr Scand200310828391 1:STN:280:DC%2BD3s3psFOhsw%3D%3D 12823164 10.1034/j.1600-0447.2003.00158.x
   PubMed Web of Science ®Google Scholar
• Bilgi N, Bell K, Ananthakrishnan AN, Atallah EImatinib and Panax ginseng: a potential interaction resulting in liver toxicityAnn Pharmacother2010445926928 20332334 10.1345/aph.1M715
   PubMed Web of Science ®Google Scholar
• Bos R, Hendriks H, Scheffer J, Woerdenbag HCytotoxic potential of valerian constituents and valerian tincturesPhytomedicine199853219225 1:CAS:528:DyaK1cXjslWntbg%3D 23195845 10.1016/S0944-7113(98)80032-9
   PubMed Web of Science ®Google Scholar
• Dalla Corte C, Fachinetto R, Colle D, Pereira R, Avila D, Villarinho J, et al.Potentially adverse interactions between haloperidol and valerianFood Chem Toxicol200846723692375 1:CAS:528:DC%2BD1cXmvVKqtb0%3D 18474410 10.1016/j.fct.2008.03.019
   PubMed Web of Science ®Google Scholar
• Berdai MA, Labib S, Chetouani K, Harandou MCase report—Atropa Belladonna intoxication: a case reportPan Afr Med J201211172 22655106 3361210
   PubMedGoogle Scholar
• Çaksen H, Odabaş D, Akbayram S, Cesur Y, Arslan Ş, Üner A, et al.Deadly nightshade (Atropa belladonna) intoxication: an analysis of 49 childrenHum Exp Toxicol20032212665668 14992329 10.1191/0960327103ht404oa
   PubMed Web of Science ®Google Scholar
• Lapi F, Gallo E, Giocaliere E, Vietri M, Baronti R, Pieraccini G, et al.Acute liver damage due to Serenoa repens: a case reportBr J Clin Pharmacol2010695558 20573093 2856058 10.1111/j.1365-2125.2010.03618.x
   PubMed Web of Science ®Google Scholar
• Agbabiaka TB, Pittler MH, Wider B, Ernst ESerenoa repens (Saw Palmetto) a systematic review of adverse eventsDrug Saf200932637647 19591529 10.2165/00002018-200932080-00003
   PubMed Web of Science ®Google Scholar
• Rahman N, Fazilah A, Effarizah MToxicity of nutmeg (myristicin): a reviewInt J Adv Sci Eng Inf Technol2015536164
   Google Scholar
• Arumugam G, Purushotham B, Swamy MK. Myristica fragrans Houtt.: botanical, pharmacological, and toxicological aspects. Natural Bio-active Compounds: Volume 2: Chemistry, Pharmacology Health Care Practices. 2019:81–106.
   Google Scholar
• Jain R, Sharma A, Gupta S, Sarethy IP, Gabrani RSolanum nigrum: current perspectives on therapeutic propertiesAltern Med Rev20111617885 21438649
   PubMedGoogle Scholar
• The East African Community (EAC). Compendium of Good Manufacturing Practices (GMP) technical documents for harmonization of medicines regulation in the East African community. EAC; 2014.
   Google Scholar
• European Medicines Agency. Uptake of the traditional use registration scheme and implementation of the provisions of Directive 2004/24/EC (Status: 31 December 2016) London: European Medicines Agency; 2017. Report No.: EMA/HMPC/322570/2011 Rev. 7.
   Google Scholar
• Ghana Food and Drugs Authority. List of all registered Products: GhanaFDA; 2023. Available from: https://fdaghana.gov.gh/registered-products.php.
   Google Scholar
• National Agency for Food and Drug Administration and Control. NAFDAC Green Book: Registered Products: NAFDAC; 2023. Available from: https://greenbook.nafdac.gov.ng/.
   Google Scholar
• Zhou X, Li C-G, Chang D, Bensoussan ACurrent status and major challenges to the safety and efficacy presented by Chinese herbal medicineJ Medicines20196114 1:CAS:528:DC%2BC1MXhsFGkt7%2FI 10.3390/medicines6010014
   Google Scholar
• Scholey AB, Kennedy DOAcute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demandHum Psychopharmacol20021713544 12404705 10.1002/hup.352
   PubMed Web of Science ®Google Scholar
• Zhang M, Long Y, Sun Y, Wang Y, Li Q, Wu H, et al.Evidence for the complementary and synergistic effects of the three-alkaloid combination regimen containing berberine, hypaconitine and skimmianine on the ulcerative colitis rats induced by trinitrobenzene-sulfonic acidEur J Pharmacol20116511–3187196 1:CAS:528:DC%2BC3cXhs1ajsr3L 20969848 10.1016/j.ejphar.2010.10.030
   PubMed Web of Science ®Google Scholar
• Zhang A, Sun H, Wang XPotentiating therapeutic effects by enhancing synergism based on active constituents from traditional medicinePhytother Res2014284526533 23913598 10.1002/ptr.5032
   PubMed Web of Science ®Google Scholar
• Yuan X, Sun Y, Miao N, Sun S, Wang Y, Hu Z, et al.The synergistic anti-inflammatory effect of the combination of sodium ferulate and oxymatrine and its modulation on inflammation-associated mediators in RAW 264.7 cellsJ Ethnopharmacol2011137314771485 1:CAS:528:DC%2BC3MXhtlOktr7O 21878383 10.1016/j.jep.2011.08.031
   PubMed Web of Science ®Google Scholar
• Ness J, Johnson D, Nisly N“Polyherbacy”: herbal supplements as a form of polypharmacy in older adultsJ Gerontol A Biol Sci Med Sci2003585478 10.1093/gerona/58.5.M478
   Web of Science ®Google Scholar
• Baxter K, Driver S, Williamson E. Stockley's herbal medicines interactions: Pharmaceutical Press London, UK; 2013.
   Google Scholar
• Johri R, Zutshi UAn ayurvedic formulation ‘Trikatu’ and its constituentsJ Ethnopharmacol19923728591 1:CAS:528:DyaK3sXms1KgtQ%3D%3D 1434692 10.1016/0378-8741(92)90067-2
   PubMed Web of Science ®Google Scholar
• Darben T, Cominos B, Lee CTopical eucalyptus oil poisoningAustralas J Dermatol1998394265267 1:STN:280:DyaK1M%2Fls1WjtQ%3D%3D 9838728 10.1111/j.1440-0960.1998.tb01488.x
   PubMedGoogle Scholar
• Webb N, Pitt WHealth CEucalyptus oil poisoning in childhood: 41 cases in south-east QueenslandJ Pediatr1993295368371 1:STN:280:DyaK2c%2FlvFKgtg%3D%3D
   Google Scholar
• Aydιn A, Aktay G, Yesilada EA guidance manual for the toxicity assessment of traditional herbal medicinesNat Prod Commun201611111934578X1601101131
   Web of Science ®Google Scholar
• Rider CV, Nyska A, Cora MC, Kissling GE, Smith C, Travlos GS, et al.Toxicity and carcinogenicity studies of Ginkgo biloba extract in rat and mouse: liver, thyroid, and nose are targetsJ Toxicol Pathol2014425830843 10.1177/0192623313501235
   Google Scholar
• Mei N, Guo X, Ren Z, Kobayashi D, Wada K, Guo L, et al.Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reportsJ Environ Sci2017351128 1:CAS:528:DC%2BC2sXjtFKlsr4%3D
   Google Scholar
• Lee M, Cheng B, Che C, Hsieh DCytotoxicity assessment of Ma-huang (Ephedra) under different conditions of preparationJ Toxicol Sci2000562424430 1:CAS:528:DC%2BD3cXlsVCjuro%3D 10.1093/toxsci/56.2.424
   Google Scholar
• Haller CA, Benowitz NLAdverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloidsNEJM20003432518331838 1:CAS:528:DC%2BD3MXktlSltQ%3D%3D 11117974 10.1056/NEJM200012213432502
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Guideline on non-clinical documentation in applications for marketing authorisation/registration of well-established and traditional herbal medicinal products. European Union: European Medicines Agency; 2017.
   Google Scholar
• Dosoky NS, Setzer WNMaternal reproductive toxicity of some essential oils and their constituentsInt J Mol Sci20212252380 1:CAS:528:DC%2BB3MXotFymtb4%3D 33673548 7956842 10.3390/ijms22052380
   PubMed Web of Science ®Google Scholar
• Busse WThe significance of quality for efficacy and safety of herbal medicinal productsDrug Inf J20003411523 10.1177/009286150003400102
   Google Scholar
• Ernst EToxic heavy metals and undeclared drugs in Asian herbal medicinesTrends Pharmacol Sci2002233136139 1:CAS:528:DC%2BD38XhsFCmsLg%3D 11879681 10.1016/S0165-6147(00)01972-6
   PubMed Web of Science ®Google Scholar
• Nagajyoti PC, Lee KD, Sreekanth THeavy metals, occurrence and toxicity for plants: a reviewEnviron Chem Lett201083199216 1:CAS:528:DC%2BC3cXhtFSnsbfF 10.1007/s10311-010-0297-8
   Web of Science ®Google Scholar
• Ang HLead contamination in Eugenia dyeriana herbal preparations from different commercial sources in MalaysiaFood Chem Toxicol200846619691975 1:CAS:528:DC%2BD1cXlvVShsr0%3D 18328612 10.1016/j.fct.2008.01.037
   PubMed Web of Science ®Google Scholar
• Ałtyn I, Twarużek MMycotoxin contamination concerns of herbs and medicinal plantsJ Toxins2020123182 10.3390/toxins12030182
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues: World Health Organization; 2007.
   Google Scholar
• European Medicines Agency. Guidelines on specification: Test procedures and acceptance criteria for herbal substances, herbal preparations and herbal medicinal products. European Union: European Medicines Agency; 2006.
   Google Scholar
• Santos L, Marín S, Sanchis V, Ramos AJAgriculture. Screening of mycotoxin multicontamination in medicinal and aromatic herbs sampled in SpainJ Sci Food2009891018021807 1:CAS:528:DC%2BD1MXos1Git7Y%3D 10.1002/jsfa.3647
   Google Scholar
• Chourasia HKMycobiota and mycotoxins in herbal drugs of Indian pharmaceutical industriesMycol Res1995996697703 1:CAS:528:DyaK2MXnt1Cjurc%3D 10.1016/S0953-7562(09)80531-5
   Google Scholar
• Harris ES, Cao S, Littlefield BA, Craycroft JA, Scholten R, Kaptchuk T, et al.Heavy metal and pesticide content in commonly prescribed individual raw Chinese Herbal MedicinesSci Total Environ20114092042974305 1:CAS:528:DC%2BC3MXhtVyqtL3K 21824641 3163780 10.1016/j.scitotenv.2011.07.032
   PubMed Web of Science ®Google Scholar
• Zhi-guang H, Yue-ru L, Yu Z, Xiu-mei W, Dan C, Zhong-bin L, et al.Distribution of 19 organochlorinated pesticides residues in ginseng and soils in Jilin ProvinceChina Afr J Biotechnol201110851976419770
   Web of Science ®Google Scholar
• de Sousa Lima CM, Fujishima MAT, de Paula LB, Mastroianni PC, de Sousa FFO, da Silva JOMicrobial contamination in herbal medicines: a serious health hazard to elderly consumersBMC Complement Med Ther202020119 10.1186/s12906-019-2723-1
   PubMedGoogle Scholar
• Rajeshwari P, Raveesha KAMycological analysis and aflatoxin B1 contaminant estimation of herbal drug raw materialsAJTCAM2016135123131 1:CAS:528:DC%2BC1cXosVGisL8%3D 28487902 5416630 10.21010/ajtcam.v13i5.16
   PubMedGoogle Scholar
• Russo S, Mastropasqua M, Mosetti M, Persegani C, Paggi ALow doses of liquorice can induce hypertension encephalopathyAm J Nephrol2000202145148 1:STN:280:DC%2BD3c3jslSgug%3D%3D 10773616 10.1159/000013572
   PubMed Web of Science ®Google Scholar
• Seeff LB, Bonkovsky HL, Navarro VJ, Wang GHerbal products and the liver: a review of adverse effects and mechanismsGastroenterology2015148351732e3 1:CAS:528:DC%2BC2MXjt1arsbY%3D 25500423 10.1053/j.gastro.2014.12.004
   PubMed Web of Science ®Google Scholar
• Tovar RT, Petzel RMHerbal toxicityDis Mon20095510592641 19782820 10.1016/j.disamonth.2009.05.001
   PubMed Web of Science ®Google Scholar
• Raynor DK, Dickinson R, Knapp P, Long AF, Nicolson DJBuyer beware? Does the information provided with herbal products available over the counter enable safe use?BMC Med20119119 10.1186/1741-7015-9-94
   PubMedGoogle Scholar
• Maat HP, Lentz LImproving the usability of patient information leafletsPatient Educ Couns2010801113119 10.1016/j.pec.2009.09.030
   PubMed Web of Science ®Google Scholar
• UK Herbal Medicines Advisory Committee (HMAC) for the Herbal Medicines and Practitioners Working Group (HMPWG). Safety, regulation and herbal medicines: a review of the evidence. United Kingdom Government; 2014. https://www.gov.uk/government/publications/advice-on-regulating-herbal-medicines-and-practitioners. Accessed 09 July 2023.
   Google Scholar